Clinical trial
Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study
NCT00074607 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- December 31, 2001
- Completion date
- April 30, 2007
- Enrollment
- 10 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.